跳至主要内容
临床试验/IRCT20190806044463N1
IRCT20190806044463N1已完成2 期

The efficacy of topical interferon alpha-2b in primary and recurrent pterygium

Bagheiat-allah University of Medical Sciences0 个研究点目标入组 18 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
18

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 years 至 70 years(—)
性别
All

入选标准

  • Any patients with primary or recurrent pterygium; either unilaterally or bilaterally, who was diagnosed by an ophthalmologist

排除标准

  • Use of any topical ophthalmic drug in previous six months
  • Patients with allergy to interferon alpha-2b
  • Patients with History of Refractive Surgery
  • History of any eye diseases other than refractive errors and pterygium
  • Pregnant or lactating women

研究者

发起方
Bagheiat-allah University of Medical Sciences

相似试验